Skip to main content
. 2022 Aug 1;18(13):5070–5085. doi: 10.7150/ijbs.72706

Figure 1.

Figure 1

The life cycle of SARS-CoV-2 and potential targets for RNA therapy. All targets can be grouped into two categories. One is the anti-virus (denoted in red), such as the structure genes of viral genome. Another is the anti-host category (denoted in blue), such as ACE2 receptor.